MedTrace Logo

Performance Study of a Non-invasive Glucose Monitoring Device Prototype

NCT03519841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-10-08

No results posted yet for this study

Summary

This clinical study has been launched to collect spectral Raman data paired with validated glucose reference values in private homes of subjects.

Conditions

Interventions

DEVICE

P0.1

Investigational Medical Device collecting spectral Raman data from tissue.

Sponsors & Collaborators

  • RSP Systems A/S

    lead INDUSTRY

Principal Investigators

  • Jan Erik Henriksen, MD, PhD · Steno Diabetes Center Odense, Denmark

  • Vibe Vestergaard, Nurse · Steno Diabetes Center Odense, Denmark

Study Design

Allocation
NON_RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-13
Primary Completion
2018-10-08
Completion
2018-10-08

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03519841 on ClinicalTrials.gov